Authors:
Boiocchi, M
Caucia, F
Merli, M
Prella, D
Ungaretti, L
Citation: M. Boiocchi et al., Crystal-chemical reasons for the immiscibility of periclase and wustite under lithospheric P, T conditions, EUR J MINER, 13(5), 2001, pp. 871-881
Authors:
Boiocchi, M
De Re, V
Gasparotto, D
De Vita, S
Citation: M. Boiocchi et al., Relationship between IgR expressed by hepatitis C virus-associated non-Hodgkin lymphomas and rheumatoid factors - Response, BLOOD, 97(10), 2001, pp. 3320-3321
Authors:
Guidoboni, M
Gafa, R
Viel, A
Doglioni, C
Russo, A
Santini, A
Del Tin, L
Macri, E
Lanza, G
Boiocchi, M
Dolcetti, R
Citation: M. Guidoboni et al., Microsatellite instability and high content of activated cytotoxic lymphocytes identify colon cancer patients with a favorable prognosis, AM J PATH, 159(1), 2001, pp. 297-304
Authors:
Toffoli, G
Sorio, R
Aita, P
Crivellari, D
Corona, G
Bearz, A
Robieux, I
Colussi, AM
Stocco, F
Boiocchi, M
Citation: G. Toffoli et al., Dose-finding and pharmacologic study of chronic oral idarubicin therapy inmetastatic breast cancer patients, CLIN CANC R, 6(6), 2000, pp. 2279-2287
Authors:
Fornasarig, M
Viel, A
Valentini, M
Capozzi, E
Sigon, R
de Paoli, A
della Puppa, L
Boiocchi, M
Citation: M. Fornasarig et al., Microsatellite instability and MLH1 and MSH2 germline defects are related to clinicopathological features in sporadic colorectal cancer, ONCOL REP, 7(1), 2000, pp. 39-43
Authors:
Toffoli, G
Veronesi, A
Boiocchi, M
Crivellari, D
Citation: G. Toffoli et al., MTHFR gene polymorphism and severe toxicity during adjuvant treatment of early breast cancer with cyclophosphamide, methotrexate, and fluorouracil (CMF), ANN ONCOL, 11(3), 2000, pp. 373-374
Authors:
De Vita, S
De Re, V
Sansonno, D
Sorrentino, D
La Corte, R
Pivetta, B
Gasparotto, D
Racanelli, V
Marzotto, A
Labombarda, A
Gloghini, A
Ferraccioli, G
Monteverde, A
Carbone, A
Dammacco, F
Boiocchi, M
Citation: S. De Vita et al., Gastric mucosa as an additional extrahepatic localization of hepatitis C virus: Viral detection in gastric low-grade lymphoma associated with autoimmune disease and in chronic gastritis, HEPATOLOGY, 31(1), 2000, pp. 182-189
Authors:
Tos, APD
Doglioni, C
Piccinin, S
Sciot, R
Furlanetto, A
Boiocchi, M
Dal Cin, P
Maestro, R
Fletcher, CDM
Tallini, G
Citation: Apd. Tos et al., Coordinated expression and amplification of the MDM2, CDK4, and HMGI-C genes in atypical lipomatous tumours, J PATHOLOGY, 190(5), 2000, pp. 531-536
Authors:
De Re, V
De Vita, S
Marzotto, A
Gloghini, A
Pivetta, B
Gasparotto, D
Cannizzaro, R
Carbone, A
Boiocchi, M
Citation: V. De Re et al., Pre-malignant and malignant lymphoproliferations in an HCV-infected type II mixed cryoglobulinemic patient are sequential phases of an antigen-drivenpathological process, INT J CANC, 87(2), 2000, pp. 211-216
Authors:
Cariati, R
Zancai, P
Quaia, M
Cutrona, G
Giannini, F
Rizzo, S
Boiocchi, M
Dolcetti, R
Citation: R. Cariati et al., Retinoic acid induces persistent, RAR alpha-mediated anti-proliferative responses in Epstein-Barr virus-immortalized B lymphoblasts carrying an activated c-myc oncogene but not in Burkitt's lymphoma cell lines, INT J CANC, 86(3), 2000, pp. 375-384
Authors:
Toffoli, G
Corona, G
Tolusso, B
Sartor, F
Sorio, R
Mini, E
Boiocchi, M
Citation: G. Toffoli et al., Resistance to methotrexate in SKOV-3 cell lines after chronic exposure to carbamazepine is associated with a decreased expression of folate receptor, INT J CANC, 85(5), 2000, pp. 683-690
Authors:
Quaia, M
Zancai, P
Cariati, R
Rizzo, S
Boiocchi, M
Dolcetti, R
Citation: M. Quaia et al., Glucocorticoids promote the proliferation and antagonize the retinoic acid-mediated growth suppression of Epstein-Barr virus-immortalized B lymphocytes, BLOOD, 96(2), 2000, pp. 711-718
Authors:
De Re, V
De Vita, S
Marzotto, A
Rupolo, M
Gloghini, A
Pivetta, B
Gasparotto, D
Carbone, A
Boiocchi, M
Citation: V. De Re et al., Sequence analysis of the immunoglobulin antigen receptor of hepatitis C virus-associated non-Hodgkin lymphomas suggests that the malignant cells are derived from the rheumatoid factor-producing cells that occur mainly in type II cryoglobulinemia, BLOOD, 96(10), 2000, pp. 3578-3584
Authors:
Bogetto, L
Gabriele, E
Cariati, R
Dolcetti, R
Spessotto, P
Doglioni, C
Boiocchi, M
Perris, R
Colombatti, A
Citation: L. Bogetto et al., Bidirectional induction of the cognate receptor-ligand alpha 4/VCAM-1 pairdefines a novel mechanism of tumor intravasation, BLOOD, 95(7), 2000, pp. 2397-2406
Authors:
De Vita, S
De Re, V
Gasparotto, D
Ballare, M
Pivetta, B
Ferraccioli, G
Pileri, S
Boiocchi, M
Monteverde, A
Citation: S. De Vita et al., Oligoclonal non-neoplastic B cell expansion is the key feature of type II mixed cryoglobulinemia - Clinical and molecular findings do not support a bone marrow pathologic diagnosis of indolent B cell lymphoma, ARTH RHEUM, 43(1), 2000, pp. 94-102
Citation: M. Santarosa et al., Splice variant lacking the transactivation domain of the BRCA2 gene and mutations in the splice acceptor site of intron 2, GENE CHROM, 26(4), 1999, pp. 381-382
Authors:
Capozzi, E
Della Puppa, L
Fornasarig, M
Pedroni, M
Boiocchi, M
Viel, A
Citation: E. Capozzi et al., Evaluation of the replication error phenotype in relation to molecular andclinicopathological features in hereditary and early onset colorectal cancer, EUR J CANC, 35(2), 1999, pp. 289-295
Authors:
Corona, G
Aita, P
Sorio, R
Colussi, AM
Bearz, A
Sartor, F
Boiocchi, M
Toffoli, G
Citation: G. Corona et al., Pharmacokinetic interaction between etoposide and tamoxifen in patients with hepatocellular carcinoma, ANTI-CANC D, 10(9), 1999, pp. 815-819
Authors:
Bertolo, F
De Vita, S
Dolcetti, R
Carbone, A
Ferraccioli, GF
Bartoli, E
Boiocchi, M
Citation: F. Bertolo et al., Lack of Fas and Fas-L mutations in patients with lymphoproliferative disorders associated with Sjogren's syndrome and type II mixed cryoglobulinermia, CLIN EXP RH, 17(3), 1999, pp. 339-342
Authors:
Pivetta, B
De Vita, S
Ferraccioli, G
De Re, V
Gloghini, A
Marzotto, A
Caruso, G
Dolcetti, R
Bartoli, E
Carbone, A
Boiocchi, M
Citation: B. Pivetta et al., T cell receptor repertoire in B cell lymphoproliferative lesions in primary Sjogren's syndrome, J RHEUMATOL, 26(5), 1999, pp. 1101-1109
Authors:
De Cicco, M
Macor, F
Robieux, I
Zanette, G
Fantin, D
Fabiani, F
Nicolosi, G
Fracasso, A
Toffoli, G
Santantonio, C
Lestuzzi, C
Matovic, M
Boiocchi, M
Citation: M. De Cicco et al., Pharmacokinetic and pharmacodynamic effects of high-dose continuous intravenous verapamil infusion: Clinical experience in the intensive care unit, CRIT CARE M, 27(2), 1999, pp. 332-339